OUTCOMES OF CHRONIC PHASE CHRONIC MYELOID LEUKEMIA PATIENTS WITH 10%<= AND > 10% BCR-ABL1 (IS) TRANSCRIPT LEVELS AFTER 3 MONTHS OF GENERIC IMATINIB TREATMENT
| dc.contributor.author | Aydinli, F. | |
| dc.contributor.author | Erdogan, I. | |
| dc.contributor.author | Ayer, M. | |
| dc.contributor.author | Kantarcioglu, B. | |
| dc.contributor.author | Demirel, N. | |
| dc.contributor.author | Aydin, D. | |
| dc.contributor.author | Yokus, O. | |
| dc.contributor.author | Sadri, S. | |
| dc.contributor.author | Ozbek, U. | |
| dc.contributor.author | Aydin, Y. | |
| dc.contributor.author | Berk, S. | |
| dc.contributor.author | Tuzuner, N. | |
| dc.contributor.author | Soysal, T. | |
| dc.contributor.author | Aydin, S. Ongoren | |
| dc.contributor.author | Yalniz, F. F. | |
| dc.contributor.author | Salihoglu, A. | |
| dc.contributor.author | Eskazan, A. E. | |
| dc.contributor.author | Ar, M. C. | |
| dc.contributor.author | Baslar, Z. | |
| dc.contributor.author | Elverdi, Tuğrul | |
| dc.date.accessioned | 2021-03-04T12:30:57Z | |
| dc.date.available | 2021-03-04T12:30:57Z | |
| dc.identifier.citation | Baslar Z., Eskazan A. E. , Ayer M., Kantarcioglu B., Demirel N., Aydin D., Aydinli F., Yokus O., Sadri S., Erdogan I., et al., "OUTCOMES OF CHRONIC PHASE CHRONIC MYELOID LEUKEMIA PATIENTS WITH 10%<= AND > 10% BCR-ABL1 (IS) TRANSCRIPT LEVELS AFTER 3 MONTHS OF GENERIC IMATINIB TREATMENT", 20th Congress of European-Hematology-Association, Vienna, Avusturya, 11 - 14 Haziran 2015, cilt.100, ss.439-440 | |
| dc.identifier.other | vv_1032021 | |
| dc.identifier.other | av_77ac4a24-600b-4777-8611-15f57ac11ff3 | |
| dc.identifier.uri | http://hdl.handle.net/20.500.12627/82146 | |
| dc.language.iso | eng | |
| dc.subject | İç Hastalıkları | |
| dc.subject | HEMATOLOJİ | |
| dc.subject | Klinik Tıp | |
| dc.subject | Klinik Tıp (MED) | |
| dc.subject | Tıp | |
| dc.subject | Sağlık Bilimleri | |
| dc.subject | Dahili Tıp Bilimleri | |
| dc.subject | Hematoloji | |
| dc.title | OUTCOMES OF CHRONIC PHASE CHRONIC MYELOID LEUKEMIA PATIENTS WITH 10%<= AND > 10% BCR-ABL1 (IS) TRANSCRIPT LEVELS AFTER 3 MONTHS OF GENERIC IMATINIB TREATMENT | |
| dc.type | Bildiri | |
| dc.contributor.department | İstanbul Üniversitesi , , | |
| dc.identifier.volume | 100 | |
| dc.contributor.firstauthorID | 147140 |
Files in this item
| Files | Size | Format | View |
|---|---|---|---|
|
There are no files associated with this item. |
|||
This item appears in the following Collection(s)
-
Bildiri [64839]